Envelope glycoprotein gp120 of human immunodeficiency virus type 1 (HIV-1) is known to inhibit T-cell function, but little is known about the mechanisms of this immunosuppression. Pretreatment of a CD41 tetanus toxoidspecific T-cell clone with soluble gpl20 was found to exert a dose-dependent inhibition of soluble antigen-driven or anti-CD3 monoclonal antibody-driven proliferative response, interleukin 2 (IL-2) production, and surface 1L-2 receptor (IL-2R) a-chain expression, all of which were reversed by the addition of exogenous IL-2. mRNA for the gene encoding IL-2 was suppressed by treatment with gpl20, but IL-2R gene transcription was not inhibited. Bypass activation ofthe T-cefl clone with phorbol 12-myristate 13-acetate plus ionomycin was unaffected by gpl20 pretreatment. Thus, gpl2O-CD4 interaction interferes with an essential role of the CD4 molecule in signal transduction through the CD3-antigen receptor (Ti) complex. Such a mechanism of gp120-induced immunosuppression, if operative in vivo, could contribute to the depressed specific immune responses associated with HIV infection.